Best Healthcare Stocks Ranked by Wall Street Score
Healthcare includes businesses with very different economics—from profitable providers and device makers to development-stage biotechnology companies. This list ranks the healthcare theme with Wall Street Score so users can compare the broader quality and valuation picture.
Current qualifying companies
No companies currently meet this screen’s validated data requirements.
How this research list is built
We select securities classified in the healthcare theme, require a current Wall Street Score, exclude ranking-ineligible securities and sort the remainder by WSS.
Coverage and data limits
These lists cover qualifying stocks with market capitalization of at least $10 billion, complete scoring inputs and a financial refresh within 240 days. They do not cover every listed company. Quotes and filings may be delayed, and a refresh date is not the financial reporting period. Revenue CAGR measures annualized historical growth, not a forecast. Check dividend history for the yield basis and any special payments.
Separate approved products from development programs
Identify whether revenue comes from marketed treatments, devices, services or another activity. Development-stage biotechnology should not be compared mechanically with an established provider. For drug developers, read trial stage, endpoints, enrollment, regulatory status and cash runway. A pipeline announcement does not establish future approval or sales.
Check concentration and funding needs
Review dependence on a single drug, patent, customer or reimbursement arrangement. A company can report strong historical margins while facing a patent expiry or a costly launch. Compare cash use with available funding and potential dilution. This industry screen does not evaluate clinical evidence or replace company and regulator disclosures.
How to use the ranking
Open the individual company pages behind the current ranking and compare the headline score with revenue, earnings, free cash flow, cash, debt, valuation, competitive position and company-specific risks. A screening result is a reason to research further, not a forecast.
Questions investors ask
The answers below explain how to interpret this screen and its limitations.
- What types of companies are in healthcare stocks?
Healthcare can include providers, insurers, medical-device companies, pharmaceutical businesses and biotechnology firms, each with different risk profiles. - Why can healthcare rankings change quickly?
Earnings, trial results, regulatory decisions, reimbursement changes and financing events can materially alter a healthcare company's risk and valuation.
Continue your research
Published by Wall Street Score Research. Editorial standards · AI disclosure.
Educational research only. Rankings and scores are model outputs based on available data, not personalized investment advice or guarantees of future performance.